Delavirdine is indicated in combination with protease inhibitors and nucleoside reverse transcriptase inhibitor for the treatment of HIV-infection.

• 抗HIV新药地拉韦定是一种非核苷类的逆转录酶抑制剂，是由法玛西亚普强公司研制开发的。